Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Cardiac Magnetic Resonance Parameters in Patients With ST-Segment Elevation Myocardial Infarction

NCT07072858 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT07072858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07072858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Cardiac Magnetic Resonance Parameters in Patients With ST-Segment Elevation Myocardial Infarction
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2014
Completion date
December 30, 2025
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), heart ventricles, magnetic resonance imaging (mri), myocardial infarction (mi), prognosis, st segment elevation myocardial infarction (stemi), ventricular dysfunction